NCT07082751 - Prognostic Model for MASLD Related Cirrhosis | Biotech Hunter

Enrollment

228

Participants

Timeline

Start Date

August 13, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions

Metabolic Dysfunction Associated Steatotic Liver DiseaseCompensated Cirrhosis

Interventions

BEHAVIORAL

Lifestyle Guidance

Trial Locations (9)

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing University of Chinese Medicine Dongfang Hospital, Beijing

Beijing Ditan Hospital, Capital Medical University, Beijing

Beijing Luhe Hospital, Capital Medical University, Beijing

Beijing Tsinghua Changgung Hospital, Beijing

Beijing Youan Hospital, Capital Medical University, Beijing

Peking University People's Hospital, Beijing

Tianjin Second People's Hospital, Tianjin

Beijing Hospital of Traditional Chinese Medicine, Beijing

All Listed Sponsors

lead

Beijing Friendship Hospital

OTHER